Viewing Study NCT06225635


Ignite Creation Date: 2025-12-24 @ 10:29 PM
Ignite Modification Date: 2025-12-25 @ 8:03 PM
Study NCT ID: NCT06225635
Status: COMPLETED
Last Update Posted: 2024-01-26
First Post: 2021-12-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab
Sponsor: Shin Poong Pharmaceutical Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module